New device aims to unclog stents in leg veins
NCT ID NCT06394739
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 35 times
Summary
This study tests a new device called the RevCore Thrombectomy Catheter to treat blocked stents in the leg veins. About 100 adults with stents that have been in place for at least 6 weeks will be enrolled. The device is inserted into the vein to remove the blockage and restore blood flow. The main goal is to see if the device can successfully reopen the stent.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IN-STENT THROMBOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Allegheny Health Network Research Institute
RECRUITINGPittsburgh, Pennsylvania, 15212, United States
Contact
Contact
-
El Paso Cardiology Associates
RECRUITINGEl Paso, Texas, 79902, United States
Contact
Contact
-
Medstar Health Research Institute
RECRUITINGWashington D.C., District of Columbia, 20010, United States
Contact
Contact
Contact
-
Mission Health
RECRUITINGAsheville, North Carolina, 28801, United States
Contact
Contact
-
New York University- Langone
RECRUITINGNew York, New York, 10016, United States
Contact
Contact
-
Ohio State University
RECRUITINGColumbus, Ohio, 23210, United States
Contact
Contact
-
Sentara
RECRUITINGNorfolk, Virginia, 23507, United States
Contact
Contact
-
Spartanburg Medical Center
RECRUITINGSpartanburg, South Carolina, 29303, United States
Contact
Contact
-
St. Luke's Hospital Boise
RECRUITINGBoise, Idaho, 83712, United States
Contact
Contact
-
Thomas Jefferson University
WITHDRAWNPhiladelphia, Pennsylvania, 19107, United States
-
UH Cleveland Medical Center
RECRUITINGCleveland, Ohio, 44106, United States
Contact
Contact
-
University of Maryland
RECRUITINGBaltimore, Maryland, 21201, United States
Contact
Contact
-
University of Pennsylvania
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
Contact
Contact
-
University of Washington
RECRUITINGSeattle, Washington, 98133, United States
Contact
Contact
-
West Virginia University- Ruby Memorial
RECRUITINGMorgantown, West Virginia, 26506, United States
Contact
Contact
-
Yale University
RECRUITINGNew Haven, Connecticut, 06511, United States
Contact
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
RevCore Thrombectomy Catheter (device)
What this could lead to
If successful, this device could offer a new way to quickly reopen blocked stents in leg veins, potentially reducing complications like pain and swelling.
What could go wrong
This is an early study with only 100 people, so results may not apply to everyone. The device may not work for all types of stent blockages, and there are risks like vessel damage or incomplete clearing.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.